High-dose immunoglobulin therapy (IVIG) in inclusion body myositis (IBM): A double-blind, placebo-controlled study - Walter, MC; Lochmüller, H; Toepfer, M; Schlotter, B; Reilich, P; Schröder, M; Müller-Felber, W; Pongratz, D (J Neurol, 2000)